Literature DB >> 17160432

Study comparing two types of screening provision for people with von Hippel-Lindau disease.

Lindsay Fraser1, Sally Watts, Anna Cargill, Stephen Sutton, Shirley Hodgson.   

Abstract

Patients diagnosed with von Hippel-Lindau disease (vHL) require life-long surveillance for this multi-system disease. It is therefore important to assess the comprehensiveness of screening provision, as well as identify what type of screening service is most likely to encourage regular patient attendance. This descriptive study reports on two types of screening service: single appointment One Stop (OS) clinics and multiple appointment Ad Hoc (AH) clinics. One hundred and seventeen vHL patients from eight regional genetics centres were approached to take part. Seventy-two (61.5%) returning a completed study questionnaire: fifty-four (75%) were screened at OS clinics and eighteen (25%) at AH clinics. Comprehensiveness of screening, attendance rates, patient ratings of quality of care and levels of psychological morbidity were compared between the two types of service. While levels of disease severity were similar in patients screened at OS and AH clinics, those seen at OS clinics were screened for twice as many site-specific vHL manifestations compared to those seen at AH clinics (P < 0.0001). More patients at OS clinics regularly attended their screening appointments compared to those at AH clinics (P = 0.0045). There was no difference in the quality of care reported by patients attending the two types of screening service and few problems were reported. Twenty-nine percent of respondents were categorised as clinically anxious and 13% as clinically depressed. These findings suggest that an optimum vHL screening service is one based on OS clinics offering regular comprehensive surveillance and psychological support.

Entities:  

Mesh:

Year:  2007        PMID: 17160432     DOI: 10.1007/s10689-006-9111-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  34 in total

1.  Uptake of genetic testing for cancer predisposition.

Authors:  D G Evans; E R Maher; R Macleod; D R Davies; D Craufurd
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  Adjusting for patient characteristics when analyzing reports from patients about hospital care.

Authors:  J L Hargraves; I B Wilson; A Zaslavsky; C James; J D Walker; G Rogers; P D Cleary
Journal:  Med Care       Date:  2001-06       Impact factor: 2.983

3.  Racial and ethnic differences in a patient survey: patients' values, ratings, and reports regarding physician primary care performance in a large health maintenance organization.

Authors:  J L Murray-García; J V Selby; J Schmittdiel; K Grumbach; C P Quesenberry
Journal:  Med Care       Date:  2000-03       Impact factor: 2.983

4.  Quantitative and qualitative assessment of women's experience of a one-stop menstrual clinic in comparison with traditional gynaecology clinics.

Authors:  J I Abu; M A Habiba; R Baker; A W Halligan; N J Naftalin; R Hsu; N Taub
Journal:  BJOG       Date:  2001-09       Impact factor: 6.531

5.  Retinal angiomatosis and von Hippel-Lindau disease.

Authors:  K M Kreusel; N E Bechrakis; T Heinichen; L Neumann; H P Neumann; M H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2000-11       Impact factor: 3.117

6.  Attitudes of von Hippel-Lindau disease patients towards presymptomatic genetic diagnosis in children and prenatal diagnosis.

Authors:  M Levy; S Richard
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

Review 7.  The role of cancer worry in cancer screening: a theoretical and empirical review of the literature.

Authors:  Jennifer L Hay; Tamara R Buckley; Jamie S Ostroff
Journal:  Psychooncology       Date:  2005-07       Impact factor: 3.894

8.  Continuity of care in general practice: a survey of patients' views.

Authors:  Henk Schers; Sophie Webster; Henk van den Hoogen; Anthony Avery; Richard Grol; Wil van den Bosch
Journal:  Br J Gen Pract       Date:  2002-06       Impact factor: 5.386

9.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

Review 10.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

View more
  1 in total

1.  Unintended diagnosis of Von Hippel Lindau syndrome using Array Comparative Genomic Hybridization (CGH): counseling challenges arising from unexpected information.

Authors:  Jennifer Hogan; A Turner; K Tucker; L Warwick
Journal:  J Genet Couns       Date:  2012-08-16       Impact factor: 2.537

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.